Results 11 to 20 of about 1,804,243 (315)

Artemether for severe malaria [PDF]

Cochrane Database of Systematic Reviews, 2019
In 2011 the World Health Organization (WHO) recommended parenteral artesunate in preference to quinine as first-line treatment for people with severe malaria. Prior to this recommendation many countries, particularly in Africa, had begun to use artemether, an alternative artemisinin derivative.
Esu, Ekpereonne B, Effa, Emmanuel E, Opie, Oko N, Meremikwu, Martin M   +3 more
openaire   +3 more sources

Assessing the severity of malaria [PDF]

BMJ, 2003
Life threatening malaria may develop even in patients who appear relatively well at ...
Moore, David AJ, Jennings, Richard M, Doherty, Tom F, Lockwood, Diana N, Chiodini, Peter L, Wright, Stephen G, Whitty, Christopher JM   +6 more
openaire   +3 more sources

Treating severe malaria [PDF]

BMJ, 2005
Rectal artemether may be as good as intravenous quinine E very year over a million children die of malaria in Africa. In many settings, especially rural ones, most fatalities due to malaria occur outside hospital, although a substantial proportion of these children will have made contact with some level of healthcare in their final illness.1 Of those
Whitty, Christopher JM, Ansah, Evelyn, Reyburn, Hugh   +2 more
openaire   +3 more sources

Artemether for severe malaria [PDF]

Cochrane Database of Systematic Reviews, 2014
In 2011 the World Health Organization (WHO) recommended parenteral artesunate in preference to quinine as first-line treatment for people with severe malaria. Prior to this recommendation, many countries, particularly in Africa, had begun to use artemether, an alternative artemisinin derivative.
Esu, Ekpereonne, Effa, Emmanuel E, Opie, Oko N, Uwaoma, Amirahobu, Meremikwu, Martin M   +4 more
openaire   +2 more sources

Severe falciparum malaria in Gabonese children: clinical and laboratory features. [PDF]

, 2005
BACKGROUND: Malaria continues to claim one to two million lives a year, mainly those of children in sub-Saharan Africa. Reduction in mortality depends, in part, on improving the quality of hospital care, the training of healthcare workers and ...
Mboza, Béatrice, Planche, Timothy, Mboza, B, Jarvis, J, Mboza Béatrice, Eric Kendjo, Kendjo Eric, Arnaud Dzeing-Ella, Mbounja, Monique, Jarvis Joseph, Kombila, Maryvonne, Planche, T, Maryvonne Kombila, Tchoua, R, Tchoua, Rose, Monique Mbounja, Peter G Kremsner, Nze Obiang, PC, Kombila, M, Ngou-Milama Edouard, Planche Timothy, Ulrich Muller-Roemer, Sanjeev Krishna, Ngou-Milama, Edouard, Pascal C Nze Obiang, Kombila Maryvonne, Timothy Planche, Béatrice Mboza, Kendjo, E, Rose Tchoua, Nze Obiang, Pascal C, Dzeing-Ella Arnaud, Kendjo, Eric, Jarvis, Joseph, Nze Obiang Pascal C, Kremsner, Peter G, Muller-Roemer Ulrich, Ngou-Milama, E, Krishna Sanjeev, Tchoua Rose, Muller-Roemer, U, Kremsner, PG, Krishna, S, Edouard Ngou-Milama, Dzeing-Ella, Arnaud, Kremsner Peter G, Krishna, Sanjeev, Mbounja, M, Muller-Roemer, Ulrich, Dzeing-Ella, A, Joseph Jarvis, Mbounja Monique   +51 more
core   +1 more source

Severe vivax malaria: Newly recognised or rediscovered? [PDF]

, 2008
Stephen Rogerson and Richard Carter discuss two new studies that challenge current dogma by suggesting that vivax malaria can cause severe ...
Carter Richard, Carter, Richard, Carter, R, Stephen J Rogerson, Richard Carter, Rogerson, Stephen J., Rogerson Stephen J, Rogerson, SJ   +7 more
core   +2 more sources

Candidate human genetic polymorphisms and severe malaria in a Tanzanian population. [PDF]

, 2012
Human genetic background strongly influences susceptibility to malaria infection and progression to severe disease and death. Classical genetic studies identified haemoglobinopathies and erythrocyte-associated polymorphisms, as protective against severe ...
Riley, Eleanor M, Maxwell Caroline, MalariaGen Consortium, George Mtove (124816), Caroline Maxwell (124825), Eleanor M Riley, Hannah Wangai, Manjurano Alphaxard, Kirk R. Rockett (124827), Raimos Olomi (124826), Nadjm Behzad, Campino Susana G., Wangai Hannah, Rockett Kirk R., George Mtove, Hannah Wangai (124818), Christopher Drakeley, Taane G Clark, Raimos Olomi, Behzad Nadjm, Taane G. Clark (106263), Jeffreys, Anna, Maxwell, Caroline, Olomi, Raimos, Susana G. Campino (124824), Hugh Reyburn (45198), Reyburn Hugh, Drakeley Christopher, Nuno Sepulveda, Clark, Taane G, Anna Jeffreys, Rockett, Kirk R, Christopher Drakeley (124831), Manjurano, Alphaxard, Drakeley, Christopher, Caroline Maxwell, Nuno Sepulveda (124822), Susana G Campino, Behzad Nadjm (124812), Wangai, Hannah, Alphaxard Manjurano (124807), Campino, Susana G, Riley Eleanor M., Jeffreys Anna, Hugh Reyburn, Olomi Raimos, Reyburn, Hugh, Clark Taane G., Sepulveda, Nuno, Alphaxard Manjurano, Mtove George, Sepulveda Nuno, Nadjm, Behzad, Mtove, George, Anna Jeffreys (124829), Eleanor M. Riley (25407), Kirk R Rockett   +56 more
core   +1 more source

Associations between erythrocyte polymorphisms and risks of uncomplicated and severe malaria in Ugandan children: A case control study. [PDF]

PLoS ONE, 2018
BACKGROUND:Evidence for association between sickle cell and alpha thalassemia trait and severe malaria is compelling. However, for these polymorphisms associations with uncomplicated malaria, and for G6PD deficiency associations with uncomplicated and ...
Arthur Mpimbaza, Andrew Walakira, Grace Ndeezi, Anne Katahoire, Charles Karamagi, Samuel L Nsobya, Stephen Tukwasibwe, Victor Asua, Philip J Rosenthal   +8 more
doaj   +1 more source

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care. [PDF]

, 2011
BACKGROUND\ud \ud An effective malaria vaccine, deployed in conjunction with other malaria interventions, is likely to substantially reduce the malaria burden. Efficacy against severe malaria will be a key driver for decisions on implementation.
Amanda Leach, Bejon, P, Walter Otieno, Kabore, W, Solange Soulanoudjingar, Njuguna, Patricia, Daniel Ansong, Kwaku Asante, Sacarlal, J, Soulanoudjingar, Solange, Ansong, D, Greenwood, Brian, Leach, Amanda, Samwel Gesase, Gesase, Samwel, Schellenberg, D, Patricia Njuguna, Bejon, Philip, Evans, Jennifer, Greenwood, B, Ansong, Daniel, Asante, KP, Clinical Trials Partnership Committee, null null, Mary J Hamel, Leach, A, Hamel, Mary J, Salim, N, Jennifer Evans, Jahit Sacarlal, Sacarlal, Jahit, Njuguna, P, Kwaku Poku Asante, Schellenberg, David, Kamthunzi, P, Gesase, S, Kevin Marsh, Asante, Kwaku Poku, Hamel, MJ, Evans, J, Portia Kamthunzi, Vekemans, J, Brian Greenwood, Vekemans, Johan, Philip Bejon, Kamthunzi, Portia, Marsh, K, Otieno, Walter, David Schellenberg, Nahya Salim, William Kabore, Otieno, W, Kabore, William, Salim, Nahya, Soulanoudjingar, S, Marsh, Kevin, Johan Vekemans   +56 more
core   +1 more source

Severe vivax malaria in Eastern India

Asian Journal of Medical Sciences, 2015
Background: Conventionally, vivax malaria was called as benign malaria. But recent reports of severe vivax malaria were coming from different parts of the World.
Joydeep Mukherjee
doaj   +1 more source